JP2019536770A5 - - Google Patents

Download PDF

Info

Publication number
JP2019536770A5
JP2019536770A5 JP2019524074A JP2019524074A JP2019536770A5 JP 2019536770 A5 JP2019536770 A5 JP 2019536770A5 JP 2019524074 A JP2019524074 A JP 2019524074A JP 2019524074 A JP2019524074 A JP 2019524074A JP 2019536770 A5 JP2019536770 A5 JP 2019536770A5
Authority
JP
Japan
Prior art keywords
alkyl
item
heteroalkyl
amino
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2019524074A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019536770A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/060721 external-priority patent/WO2018089554A1/en
Publication of JP2019536770A publication Critical patent/JP2019536770A/ja
Publication of JP2019536770A5 publication Critical patent/JP2019536770A5/ja
Withdrawn legal-status Critical Current

Links

JP2019524074A 2016-11-09 2017-11-08 予め会合され、保護され、化学的に安定した、官能基選択的リンカー Withdrawn JP2019536770A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662419861P 2016-11-09 2016-11-09
US62/419,861 2016-11-09
PCT/US2017/060721 WO2018089554A1 (en) 2016-11-09 2017-11-08 Pre-assembled, protected, chemically stable, chemoselective linkers

Publications (2)

Publication Number Publication Date
JP2019536770A JP2019536770A (ja) 2019-12-19
JP2019536770A5 true JP2019536770A5 (enExample) 2020-12-17

Family

ID=62109408

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019524074A Withdrawn JP2019536770A (ja) 2016-11-09 2017-11-08 予め会合され、保護され、化学的に安定した、官能基選択的リンカー

Country Status (8)

Country Link
US (1) US12037311B2 (enExample)
EP (1) EP3538536A4 (enExample)
JP (1) JP2019536770A (enExample)
KR (1) KR20190082871A (enExample)
CN (2) CN110072870A (enExample)
AU (1) AU2017359448A1 (enExample)
CA (1) CA3043373A1 (enExample)
WO (1) WO2018089554A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017281039A1 (en) 2016-06-20 2019-01-24 Healthtell Inc. Methods for differential diagnosis of autoimmune diseases
JP2019526786A (ja) 2016-06-20 2019-09-19 ヘルステル・インコーポレイテッドHealthtell Inc. 自己免疫疾患の診断および処置のための方法
US12037311B2 (en) 2016-11-09 2024-07-16 Cowper Sciences Inc. Pre-assembled, protected, chemically stable, chemoselective linkers
US11359112B2 (en) 2016-11-09 2022-06-14 Cowper Sciences Inc. Coatings with tunable amine density
US11371990B2 (en) 2016-11-11 2022-06-28 Cowper Sciences Inc. Methods for identifying candidate biomarkers

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424186A (en) 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5981478A (en) 1993-11-24 1999-11-09 La Jolla Cancer Research Foundation Integrin-binding peptides
US5571639A (en) 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks
US5932546A (en) 1996-10-04 1999-08-03 Glaxo Wellcome Inc. Peptides and compounds that bind to the thrombopoietin receptor
US6261804B1 (en) 1997-01-21 2001-07-17 The General Hospital Corporation Selection of proteins using RNA-protein fusions
US6824866B1 (en) 1999-04-08 2004-11-30 Affymetrix, Inc. Porous silica substrates for polymer synthesis and assays
GB0001513D0 (en) 2000-01-25 2000-03-15 Univ Cranfield Rational design of mips using computational approach
US7109167B2 (en) * 2000-06-02 2006-09-19 Bracco International B.V. Compounds for targeting endothelial cells, compositions containing the same and methods for their use
US20030219816A1 (en) 2001-07-02 2003-11-27 Keith Solomon Composite microarray slides
CN1125488C (zh) 2000-08-25 2003-10-22 中国科学院化学研究所 一种半导体封装用的液体环氧组合物及其用途
WO2002081649A2 (en) 2001-04-06 2002-10-17 The Trustees Of The University Of Pennsylvania ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF
US20030003223A1 (en) 2001-04-07 2003-01-02 The Regents Of The University Of California Methods and compositions for binding histidine-containing proteins to substrates
GB0121602D0 (en) 2001-09-06 2001-10-24 Randox Lab Ltd Molecular array
AU2003233498A1 (en) 2002-06-10 2003-12-22 Phynexus, Inc. Biomolecule open channel solid phase extraction systems and methods
US20060013971A1 (en) 2002-10-25 2006-01-19 Tienteh Chen Porous inkjet recording material
AU2003300815A1 (en) 2002-12-05 2004-06-30 Incyte Corporation Protein modification and maintenance molecules
KR100529600B1 (ko) 2003-01-23 2005-11-22 정만길 디옥소아테미시닌 유사체, 그의 제조방법 및 그를포함하는 항암제
JP4006523B2 (ja) 2003-04-10 2007-11-14 独立行政法人産業技術総合研究所 タンパク質アレイ及びその作製方法
WO2005050224A2 (en) 2003-11-13 2005-06-02 Epitome Biosystems Inc. Small molecule and peptide arrays and uses thereof
CN100595277C (zh) 2003-11-15 2010-03-24 波利弗尔有限公司 模板固定的β发夹环模拟物及其在噬菌体展示中的用途
JP2008531764A (ja) 2005-02-23 2008-08-14 リポクセン テクノロジーズ リミテッド タンパク質の誘導体化及び結合のための活性化シアル酸誘導体
JP5755398B2 (ja) 2005-03-18 2015-07-29 ノヴォ ノルディスク アー/エス 伸長されたglp−1化合物
US7507480B2 (en) 2005-05-31 2009-03-24 Brookhaven Science Associates, Llc Corrosion-resistant metal surfaces
KR100671659B1 (ko) * 2005-12-21 2007-01-19 삼성에스디아이 주식회사 데이터 구동부 및 이를 이용한 유기 발광 표시장치와 그의구동방법
US7923054B2 (en) 2006-04-19 2011-04-12 Gore Enterprise Holdings, Inc. Functional porous substrates for attaching biomolecules
WO2007144685A1 (en) 2006-06-13 2007-12-21 Commissariat A L'energie Atomique Cd4 mimic peptides and their uses
WO2007149982A2 (en) 2006-06-22 2007-12-27 The Brigham And Women's Hospital, Inc. Diagnosis of autoimmune disease
JP2008028123A (ja) 2006-07-20 2008-02-07 Sanyo Electric Co Ltd 半導体集積回路装置の製造方法
WO2008064336A2 (en) 2006-11-22 2008-05-29 Inivitrogen Corporation Autoimmune disease biomarkers
WO2008151146A2 (en) 2007-06-01 2008-12-11 Digitab, Inc. Peptide arrays and methods of use
US20090142792A1 (en) 2007-06-21 2009-06-04 Robinson William H Biomarkers for the diagnosis of autoimmune disease
JP2011001344A (ja) 2009-04-30 2011-01-06 L'oreal Sa アミノトリアルコキシシランまたはアミノトリアルケニルオキシシラン組成物を用いたヒトケラチン繊維の明色化および/または着色ならびに装置
US20120190574A1 (en) 2009-06-19 2012-07-26 The Arizona Board of Regents, A body Corporate of the State of Arizona for and on behalf of Arizona Compound Arrays for Sample Profiling
WO2011008863A2 (en) 2009-07-14 2011-01-20 Lucia Irene Gonzalez Stereoisomer peptides and their polymer conjugates for hiv disease
WO2011041586A1 (en) 2009-09-30 2011-04-07 Virogenomics, Inc. Electromagnetic detection of analytes
US8698320B2 (en) 2009-12-07 2014-04-15 Henkel IP & Holding GmbH Curable resin compositions useful as underfill sealants for use with low-k dielectric-containing semiconductor devices
WO2011106558A1 (en) 2010-02-24 2011-09-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for autoimmune disease diagnosis, prognosis, and treatment
US20120237555A1 (en) 2011-03-16 2012-09-20 David Williams Surface coating for biomolecule immobilisation and minimisation of non-specific binding on surfaces for biomedical diagnostics
US9346892B2 (en) 2011-03-18 2016-05-24 Roche Nimble Gen, Inc. Methods for synthesis of an oligopeptide microarray
WO2013077982A1 (en) 2011-11-22 2013-05-30 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf High throughput selection of specific cell binding and lytic polypeptides
EP2812344A4 (en) 2012-02-07 2015-10-28 Vibrant Holdings Llc SUBSTRATES, PEPTIDE NETWORKS AND METHODS
US20130310265A1 (en) 2012-03-21 2013-11-21 North Carolina State University Methods of preparing cyclic peptides and uses thereof
BR112014029403A2 (pt) 2012-07-04 2018-10-09 F. Hoffmann-La Roche Ag conjugados, anticorpo e formulação farmacêutica
AU2013308682A1 (en) 2012-08-29 2015-03-12 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University Immunosignaturing: a path to early diagnosis and health monitoring
US20150241420A1 (en) 2012-09-05 2015-08-27 Arizona Board of Regents, Body Corp. of the State of Arizona, acting for and on behalf of Arizona S Methods for discovering therapeutic targets
US10046293B2 (en) 2012-10-17 2018-08-14 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona In situ chemical patterning
WO2014144383A1 (en) 2013-03-15 2014-09-18 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University Non-covalent patterned chemical features and use thereof in maldi-based quality control
TWI707038B (zh) 2013-08-05 2020-10-11 美商扭轉生物科技有限公司 重新合成之基因庫
US20160060687A1 (en) 2014-07-18 2016-03-03 Cdi Laboratories, Inc. Methods and compositions to identify, quantify, and characterize target analytes and binding moieties
PL3177640T3 (pl) 2014-08-08 2020-11-02 The Board Of Trustees Of The Leland Stanford Junior University Charakteryzujące się wysokim powinowactwem środki terapeutyczne naśladujące PD-11 i sposoby ich wykorzystania
US20160367961A1 (en) 2015-04-23 2016-12-22 Roche Sequencing Solutions, Inc. Method and composition for peptide cyclization and protease treatment
US10094825B2 (en) 2015-07-30 2018-10-09 The Florida International University Board Of Trustees Predictive biomarkers for detection of organ damage in autoimmune illnesses and other diseases
EP3436825A4 (en) 2016-04-01 2020-03-18 Healthtell Inc. NETWORK-BASED PEPTIDE BANKS FOR THE CHARACTERIZATION OF THERAPEUTIC ANTIBODIES
US11359112B2 (en) 2016-11-09 2022-06-14 Cowper Sciences Inc. Coatings with tunable amine density
US12037311B2 (en) 2016-11-09 2024-07-16 Cowper Sciences Inc. Pre-assembled, protected, chemically stable, chemoselective linkers
EP3642233A4 (en) 2017-06-19 2021-08-11 Healthtell Inc. IMMUNE SIGNATURES FOR DIFFERENTIAL DIAGNOSIS
WO2019157362A1 (en) 2018-02-09 2019-08-15 Healthtell Inc. Array-based cyclic peptide libraries
WO2020102365A1 (en) 2018-11-14 2020-05-22 Healthtell Inc. Methods of selecting functional interface mimics, and compositions thereof

Similar Documents

Publication Publication Date Title
JP2019519490A5 (enExample)
US6127154A (en) Methods for direct synthesis of compounds having complementary structure to a desired molecular entity and use thereof
JP2004501869A (ja) ヒドラジンベース及びカルボニルベースの二官能性架橋剤
JP2004535193A (ja) 鋳型化された分子およびかかる分子の使用方法
JPH09511228A (ja) 窒素を含有する結合を有するオリゴマー化合物
JP2020514299A5 (enExample)
JP2007508307A5 (enExample)
JP2003525945A5 (enExample)
EP3775261B1 (en) Target binding moiety compositions and methods of use
SG172715A1 (en) 2-2'-bis-thiazole derivatives as antiviral agents
JP2020525502A5 (enExample)
JP2019536860A5 (enExample)
US12416041B2 (en) Kits and flow cells
WO2018051569A1 (ja) 分泌型免疫グロブリンA(sIgA)結合核酸分子、sIgA分析用センサ、およびsIgAの分析方法
Tsygankova et al. Biantennary oligoglycines and glyco-oligoglycines self-associating in aqueous medium
JP2001514267A (ja) アミノアルキルトリアルキルシリルセルロースおよび表面コーティング法
AU2004272465A1 (en) Size-controlled macromolecule
US20150315129A1 (en) Processes for forming amide bonds and compositions related thereto
EP1242459A1 (en) Methods and compositions for determining the purity of chemically synthesized nucleic acids
JP2009516008A5 (enExample)
CN109790542B (zh) Pna探针
JP2019522058A5 (enExample)
CN115397831A (zh) 包含核酸寡聚物的组合物
US8853132B2 (en) Directed synthesis of oligophosphoramidate stereoisomers
DE60109739D1 (de) Verfahren zur herstellung und immobilisierung von nukleinsäure auf einem silan-modifizierten festträger